Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by Sei Investments Co.

Sei Investments Co. raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 9.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 472,169 shares of the company's stock after acquiring an additional 40,425 shares during the quarter. Sei Investments Co. owned 0.38% of Henry Schein worth $32,674,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in the stock. Smartleaf Asset Management LLC lifted its stake in shares of Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after purchasing an additional 143 shares during the period. CIBC Asset Management Inc lifted its position in shares of Henry Schein by 1.0% during the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock valued at $1,235,000 after acquiring an additional 169 shares during the period. Metis Global Partners LLC boosted its stake in shares of Henry Schein by 4.7% during the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock worth $291,000 after acquiring an additional 187 shares in the last quarter. Central Pacific Bank Trust Division grew its holdings in shares of Henry Schein by 2.0% in the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company's stock worth $706,000 after acquiring an additional 200 shares during the period. Finally, Sanctuary Advisors LLC raised its holdings in Henry Schein by 5.0% during the fourth quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company's stock worth $294,000 after purchasing an additional 203 shares during the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

Several analysts have weighed in on HSIC shares. Mizuho assumed coverage on Henry Schein in a report on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 target price on the stock. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and increased their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. UBS Group cut their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Jefferies Financial Group upped their price objective on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Finally, Wells Fargo & Company started coverage on shares of Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target for the company. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein has a consensus rating of "Moderate Buy" and an average target price of $81.10.

Insiders Place Their Bets

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Trading Down 1.1 %

Henry Schein stock traded down $0.78 during trading on Friday, reaching $68.62. The company had a trading volume of 1,028,798 shares, compared to its average volume of 1,573,330. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock's 50 day moving average price is $74.62 and its two-hundred day moving average price is $72.64. The firm has a market capitalization of $8.52 billion, a price-to-earnings ratio of 28.24, a PEG ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion for the quarter, compared to analysts' expectations of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm's quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.66 earnings per share. As a group, equities analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.